Latest filing published 02 Feb 2026 for Altimmune, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Vipin K. Garg on record concern Altimmune, Inc., in the capacity of chief executive. Over a trading history stretching from 30 April 2021 to 30 January 2026, the count stands at 34 filings.
Every open-market trade on record is a sale: 1 sale worth €219k. The rest of the record consists of 25 share grants and 8 option exercises.
The record was last updated on 2 February 2026 with an option exercise in Altimmune, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations